‘Text/HTML’ of page ‘Time to Biochemical Failure Could be Used as a Surrogate Endpoint in Treatment of Locally Advanced Prostate Cancer’
Time to Biochemical Failure Could be Used as a Surrogate Endpoint in Treatment of Locally Advanced Prostate Cancer For Immediate Release Media Contact: Angela LaPenta lapentaa@nrgoncology.org PHILADELPHIA, PA– An analysis of the NRG Oncology clinical trial NRG-RTOG 9202 showed that the interval of time to biochemical failure (IBF), or the time it takes for previously […]
Read More